Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to study safety, tolerability and pharmacokinetics of AZD1981 in healthy Japanese subjects
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental |
| |
| 2 | Experimental |
| |
| 3 | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| AZD1981 | Drug | Oral tablet, 250 mg single dose |
| |
| AZD1981 |
| Measure | Description | Time Frame |
|---|---|---|
| Adverse events | All the time | |
| Plasma drug concentration | Every hour |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical chemistry | day 1 and 9 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Elizabeth Hancox | Europe Chiltern International Ltd, Berkshire, UK | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Berkshire | United Kingdom |
Not provided
| ID | Term |
|---|---|
| C569518 | AZD1981 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
Suspension, 15, 75, 1000 and 2000 mg |
|
| Placebo | Drug |
|